Bowers, M. S., Cacheaux, L. P., Sahu, S. U., Schmidt, M. E., Sennello, J. A., Leaderbrand, K., . . . Moskal, J. R. (2019). NYX‐2925 induces metabotropic N‐methyl‐d‐aspartate receptor (NMDAR) signaling that enhances synaptic NMDAR and α‐amino‐3‐hydroxy‐5‐methyl‐4‐isoxazolepropionic acid receptor. J Neurochem.
Citación estilo ChicagoBowers, M. Scott, Luisa P. Cacheaux, Srishti U. Sahu, Mary E. Schmidt, Joseph A. Sennello, Katherine Leaderbrand, M. Amin Khan, Roger A. Kroes, and Joseph R. Moskal. "NYX‐2925 Induces Metabotropic N‐methyl‐d‐aspartate Receptor (NMDAR) Signaling That Enhances Synaptic NMDAR and α‐amino‐3‐hydroxy‐5‐methyl‐4‐isoxazolepropionic Acid Receptor." J Neurochem 2019.
Cita MLABowers, M. Scott, et al. "NYX‐2925 Induces Metabotropic N‐methyl‐d‐aspartate Receptor (NMDAR) Signaling That Enhances Synaptic NMDAR and α‐amino‐3‐hydroxy‐5‐methyl‐4‐isoxazolepropionic Acid Receptor." J Neurochem 2019.